+1-902-442-0653 Purdy’s Wharf Tower II Suite 2001 – 1969 Upper Water Street

Technology
Investors
News & Media
About Us
Contact Us
- Contact
- Newsletter Subscribe
Store

Annual Report For the Fiscal Year Ended October 31, 2024

Subscribe to Our Newsletter

Download the Company Presentation

Read in Frontiers in Immunology our Published Research

Targeted intra-tumoral hyperthermia using uniquely biocompatible gold nanorods induces strong immunogenic cell death in two immunogenically ‘cold’ tumor models - Frontiers- Sona Nanotech

Targeted intra-tumoral hyperthermia using uniquely biocompatible gold nanorods induces strong immunogenic cell death in two immunogenically ‘cold’ tumor models.

Biocompatible Nanoparticle Technology Being Used to Develop Cancer Therapies & Rapid Diagnostics

Technology

Technology Overview

Therapies

Therapies Overview
Targeted Hyperthermia Therapy (THT)
Pre-Clinical Study
Whitepapers & Publications
THT Vaccine Effect

Diagnostics

Diagnostics Overview

Investors

Share Information
Investor Presentation
Research Coverage
Financial Reports

Store

Your Cart
Order
Your Account
Shipping Information
Purchasing Information
Storage & Handling

News & Media

All News & Media
News Releases
Media Centre

About Us

Our Story
Leadership
Board of Directors
Advisory Board

Contact Us

Contact
Newsletter Subscribe

Follow Us

LinkedIn
Twitter
Youtube
Instagram
Facebook

© 2025 Sona Nanotech. All Rights Reserved.

Privacy Policy

Technology
Investors
News & Media
About Us
Contact Us
- Contact
- Newsletter Subscribe
Store